Developing a vaccine to prevent and treat cryptococcosis
Conjugate vaccines for prevention and treatment of cryptococcosis
This study is working on a new vaccine to help prevent and treat cryptococcosis, a tough fungal infection, by boosting your immune system to fight off the fungus better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10788443 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine to prevent and treat cryptococcosis, a serious fungal infection caused by Cryptococcus neoformans. The approach involves developing a conjugate vaccine that targets the polysaccharide capsule of the fungus, which is crucial for its virulence. By stimulating the immune system to produce protective antibodies, the researchers aim to improve outcomes for patients suffering from this challenging infection. The study builds on previous successes with similar vaccines for bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cryptococcosis, such as those with weakened immune systems due to conditions like HIV or those undergoing organ transplantation.
Not a fit: Patients who are not at risk for cryptococcosis or those with fully functioning immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the incidence and severity of cryptococcosis, improving patient outcomes.
How similar studies have performed: Previous research has shown success in developing conjugate vaccines for other encapsulated pathogens, suggesting a promising potential for this approach in cryptococcosis.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Casadevall, Arturo — Johns Hopkins University
- Study coordinator: Casadevall, Arturo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.